logo
logo
Sign in

Global Impingement Syndrome Market Is Estimated To Witness High Growth Owing To Rising Prevalence of Musculoskeletal Disorders

avatar
Anjali CMI
Global Impingement Syndrome Market Is Estimated To Witness High Growth Owing To Rising Prevalence of Musculoskeletal Disorders

The global Impingement Syndrome Market is estimated to be valued at US$ 4.54 billion in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Impingement syndrome is a common orthopedic condition characterized by compression or pinching of the soft tissues (tendons and bursa) between the bones in the shoulder joint. It is typically caused by repetitive overhead activities or age-related degenerative changes. The rising prevalence of musculoskeletal disorders, such as rotator cuff tears, shoulder instability, and tendinitis, is driving the demand for innovative treatment options for impingement syndrome.

One of the key advantages of treating impingement syndrome is the improvement in pain and functional ability of individuals. As the condition can significantly impact daily activities, there is a growing need for effective treatment options that can provide long-term relief. This has led to the development of advanced orthopedic devices and surgical techniques, which are driving the growth of the impingement syndrome market.

Market key trends:

One key trend in the impingement syndrome market is the increasing adoption of minimally invasive surgical procedures. Minimally invasive techniques offer several advantages over traditional open surgeries, including reduced post-operative pain, shorter hospital stays, faster recovery time, and smaller incisions. This trend is driven by the growing patient preference for minimally invasive procedures and advancements in surgical instruments and technologies.

For example, arthroscopic surgery has gained popularity in the treatment of impingement syndrome. It involves the use of specialized instruments and a small camera (arthroscope) inserted through tiny incisions in the shoulder joint. Surgeons can visualize and repair the damaged tissues without fully opening the joint. This less invasive approach reduces the risk of complications, improves patient outcomes, and contributes to the overall growth of the impingement syndrome market.

PEST Analysis:

- Political: Regulations and policies related to healthcare infrastructure and reimbursement systems can impact the adoption of impingement syndrome treatments.

- Economic: Rising healthcare expenditure and favorable reimbursement policies contribute to the growth of the impingement syndrome market.

- Social: Increasing awareness about musculoskeletal disorders and the availability of advanced treatment options drive market growth.

- Technological: Advancements in orthopedic devices, surgical instruments, and imaging techniques support the diagnosis and treatment of impingement syndrome.

Key Takeaways:

1: The global Impingement Syndrome Market Demand is expected to witness high growth, exhibiting a CAGR of 7.5% over the forecast period, due to increasing prevalence of musculoskeletal disorders. The rising demand for effective treatment options and the advantages offered by these treatments, such as pain relief and improved functionality, are driving market growth.

2: Regionally, North America dominates the impingement syndrome market, owing to a well-established healthcare infrastructure, high healthcare spending, and the presence of key market players. However, Asia Pacific is expected to witness the fastest growth during the forecast period, primarily due to the rising geriatric population and increasing healthcare expenditure in emerging economies.

3: Key players operating in the global impingement syndrome market are Johnson & Johnson (DePuy Synthes), Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, NuVasive, Inc., Globus Medical, Inc., Wright Medical Group N.V., Arthrex, Inc., DJO Global, Inc., Össur hf., CONMED Corporation, Breg, Inc., Orthofix Medical Inc., and Bioventus LLC. These companies are focusing on product innovation, strategic partnerships, and mergers and acquisitions to gain a competitive edge in the market.

In conclusion, the impingement syndrome market is experiencing significant growth due to the increasing prevalence of musculoskeletal disorders and the demand for effective treatment options. The adoption of minimally invasive surgical procedures and advancements in orthopedic devices are driving the market. With the growing awareness about the condition and advancements in healthcare infrastructure, the impingement syndrome market is expected to witness continued growth in the coming years.

collect
0
avatar
Anjali CMI
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more